Astrazeneca/Oxford get a poor grade for transparency and rigor when it comes to the vaccine trial results they have reported. This is not like Pfizer or Moderna where we had the protocols in advance and a pre-specified primary analysis was reported. 1/5
— Natalie E. Dean, PhD (@nataliexdean) November 24, 2020
Tagged COVIDVaccine studies